Bright light therapy as an adjunctive treatment with risperidone in patients with delirium: A randomized, open, parallel group study

Jaewon Yang, Wonseok Choi, Young-Hoon Ko, Sook Haeng Joe, Changsu Han, Yong Ku Kim

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Objective: The purpose of this study was to determine the effect of adjuvant light therapy with antipsychotic treatment in patients with delirium. Methods: Thirty-six patients were referred to the consulting psychiatry division of our hospital for a disturbance in consciousness. The patients were randomized to risperidone (n=16) or risperidone with light therapy (n=20). They were evaluated on Day 0 (baseline) and on Days 1 to 5 with the Delirium Rating Scale (DRS) and the Memorial Delirium Assessment Scale (MDAS). Sleep parameters were measured using a sleep log. Results: Mean DRS and MDAS scores decreased significantly over time in both treatment groups. Risperidone with light therapy group showed a significantly greater decrease in the DRS score than the risperidone-only group (F=2.87, P=.025), but the MDAS score was not significantly different between the two groups. There was a significant improvement in total sleep time (F=2.07, P=.037) and sleep efficiency (F=2.79, P=.029) in the risperidone with light therapy group than in the risperidone-only group. Conclusions: Our results indicate that risperidone with light therapy may be a helpful adjuvant treatment for patients with delirium. Adequately powered studies with a head-to-head comparison design are mandatory to confirm our findings.

Original languageEnglish
Pages (from-to)546-551
Number of pages6
JournalGeneral Hospital Psychiatry
Volume34
Issue number5
DOIs
Publication statusPublished - 2012 Sep 1

Fingerprint

Phototherapy
Risperidone
Delirium
Sleep
Therapeutics
Consciousness
Antipsychotic Agents
Psychiatry

Keywords

  • Adjunctive treatment
  • Delirium
  • Light therapy
  • Sleep efficiency
  • Total sleep time

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Bright light therapy as an adjunctive treatment with risperidone in patients with delirium : A randomized, open, parallel group study. / Yang, Jaewon; Choi, Wonseok; Ko, Young-Hoon; Joe, Sook Haeng; Han, Changsu; Kim, Yong Ku.

In: General Hospital Psychiatry, Vol. 34, No. 5, 01.09.2012, p. 546-551.

Research output: Contribution to journalArticle

@article{9a546601c73b4146a674c59338afb693,
title = "Bright light therapy as an adjunctive treatment with risperidone in patients with delirium: A randomized, open, parallel group study",
abstract = "Objective: The purpose of this study was to determine the effect of adjuvant light therapy with antipsychotic treatment in patients with delirium. Methods: Thirty-six patients were referred to the consulting psychiatry division of our hospital for a disturbance in consciousness. The patients were randomized to risperidone (n=16) or risperidone with light therapy (n=20). They were evaluated on Day 0 (baseline) and on Days 1 to 5 with the Delirium Rating Scale (DRS) and the Memorial Delirium Assessment Scale (MDAS). Sleep parameters were measured using a sleep log. Results: Mean DRS and MDAS scores decreased significantly over time in both treatment groups. Risperidone with light therapy group showed a significantly greater decrease in the DRS score than the risperidone-only group (F=2.87, P=.025), but the MDAS score was not significantly different between the two groups. There was a significant improvement in total sleep time (F=2.07, P=.037) and sleep efficiency (F=2.79, P=.029) in the risperidone with light therapy group than in the risperidone-only group. Conclusions: Our results indicate that risperidone with light therapy may be a helpful adjuvant treatment for patients with delirium. Adequately powered studies with a head-to-head comparison design are mandatory to confirm our findings.",
keywords = "Adjunctive treatment, Delirium, Light therapy, Sleep efficiency, Total sleep time",
author = "Jaewon Yang and Wonseok Choi and Young-Hoon Ko and Joe, {Sook Haeng} and Changsu Han and Kim, {Yong Ku}",
year = "2012",
month = "9",
day = "1",
doi = "10.1016/j.genhosppsych.2012.05.003",
language = "English",
volume = "34",
pages = "546--551",
journal = "General Hospital Psychiatry",
issn = "0163-8343",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Bright light therapy as an adjunctive treatment with risperidone in patients with delirium

T2 - A randomized, open, parallel group study

AU - Yang, Jaewon

AU - Choi, Wonseok

AU - Ko, Young-Hoon

AU - Joe, Sook Haeng

AU - Han, Changsu

AU - Kim, Yong Ku

PY - 2012/9/1

Y1 - 2012/9/1

N2 - Objective: The purpose of this study was to determine the effect of adjuvant light therapy with antipsychotic treatment in patients with delirium. Methods: Thirty-six patients were referred to the consulting psychiatry division of our hospital for a disturbance in consciousness. The patients were randomized to risperidone (n=16) or risperidone with light therapy (n=20). They were evaluated on Day 0 (baseline) and on Days 1 to 5 with the Delirium Rating Scale (DRS) and the Memorial Delirium Assessment Scale (MDAS). Sleep parameters were measured using a sleep log. Results: Mean DRS and MDAS scores decreased significantly over time in both treatment groups. Risperidone with light therapy group showed a significantly greater decrease in the DRS score than the risperidone-only group (F=2.87, P=.025), but the MDAS score was not significantly different between the two groups. There was a significant improvement in total sleep time (F=2.07, P=.037) and sleep efficiency (F=2.79, P=.029) in the risperidone with light therapy group than in the risperidone-only group. Conclusions: Our results indicate that risperidone with light therapy may be a helpful adjuvant treatment for patients with delirium. Adequately powered studies with a head-to-head comparison design are mandatory to confirm our findings.

AB - Objective: The purpose of this study was to determine the effect of adjuvant light therapy with antipsychotic treatment in patients with delirium. Methods: Thirty-six patients were referred to the consulting psychiatry division of our hospital for a disturbance in consciousness. The patients were randomized to risperidone (n=16) or risperidone with light therapy (n=20). They were evaluated on Day 0 (baseline) and on Days 1 to 5 with the Delirium Rating Scale (DRS) and the Memorial Delirium Assessment Scale (MDAS). Sleep parameters were measured using a sleep log. Results: Mean DRS and MDAS scores decreased significantly over time in both treatment groups. Risperidone with light therapy group showed a significantly greater decrease in the DRS score than the risperidone-only group (F=2.87, P=.025), but the MDAS score was not significantly different between the two groups. There was a significant improvement in total sleep time (F=2.07, P=.037) and sleep efficiency (F=2.79, P=.029) in the risperidone with light therapy group than in the risperidone-only group. Conclusions: Our results indicate that risperidone with light therapy may be a helpful adjuvant treatment for patients with delirium. Adequately powered studies with a head-to-head comparison design are mandatory to confirm our findings.

KW - Adjunctive treatment

KW - Delirium

KW - Light therapy

KW - Sleep efficiency

KW - Total sleep time

UR - http://www.scopus.com/inward/record.url?scp=84865369427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865369427&partnerID=8YFLogxK

U2 - 10.1016/j.genhosppsych.2012.05.003

DO - 10.1016/j.genhosppsych.2012.05.003

M3 - Article

C2 - 22717090

AN - SCOPUS:84865369427

VL - 34

SP - 546

EP - 551

JO - General Hospital Psychiatry

JF - General Hospital Psychiatry

SN - 0163-8343

IS - 5

ER -